G Liu1, X Ke2, Z-B Huang1, L-C Wang1, Z-N Huang1, Y Guo1, M Long3,4, X-X Liao5,6. 1. Department of Cardiology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. 2. Department of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, China. 3. Department of Cardiology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. longming_sys@163.com. 4. , 58 Zhongshan Rd II, 510080, Guangzhou, China. longming_sys@163.com. 5. Department of Cardiology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. liaoxinx@mail.sysu.edu.cn. 6. , 58 Zhongshan Rd II, 510080, Guangzhou, China. liaoxinx@mail.sysu.edu.cn.
Abstract
BACKGROUND: The efficacy of final kissing balloon (FKB) inflation in one-stent techniques for bifurcation lesions is controversial. The goal of the present study was to investigate the impact of FKB on long-term clinical outcomes in one-stent strategies. METHODS: A literature search of the PubMed, Embase, and Cochrane Library databases was undertaken through August 2017. The primary outcome was major adverse cardiac events (MACE), defined as the composite of cardiac death, myocardial infarction, and target lesion revascularization. Overall hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using the random-effects model. RESULTS: Ten studies comprising 7364 patients treated with a one-stent technique were included in the analysis. Overall, FKB did not demonstrate a significant reduction in MACE compared with non-FKB in both randomized trials (HR: 1.13; 95% CI: 0.65-1.98) and observational studies (HR: 0.86; 95% CI: 0.61-1.20). The risk of cardiac death (HR: 0.89; 95% CI: 0.53-1.49), myocardial infarction (HR: 0.76; 95% CI: 0.53-1.09), and target lesion revascularization (HR: 0.96; 95% CI: 0.74-1.23) was also similar in both groups. CONCLUSION: FKB may not be mandatory and a selective FKB strategy might be more justified in one-stent techniques for bifurcation lesions.
BACKGROUND: The efficacy of final kissing balloon (FKB) inflation in one-stent techniques for bifurcation lesions is controversial. The goal of the present study was to investigate the impact of FKB on long-term clinical outcomes in one-stent strategies. METHODS: A literature search of the PubMed, Embase, and Cochrane Library databases was undertaken through August 2017. The primary outcome was major adverse cardiac events (MACE), defined as the composite of cardiac death, myocardial infarction, and target lesion revascularization. Overall hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using the random-effects model. RESULTS: Ten studies comprising 7364 patients treated with a one-stent technique were included in the analysis. Overall, FKB did not demonstrate a significant reduction in MACE compared with non-FKB in both randomized trials (HR: 1.13; 95% CI: 0.65-1.98) and observational studies (HR: 0.86; 95% CI: 0.61-1.20). The risk of cardiac death (HR: 0.89; 95% CI: 0.53-1.49), myocardial infarction (HR: 0.76; 95% CI: 0.53-1.09), and target lesion revascularization (HR: 0.96; 95% CI: 0.74-1.23) was also similar in both groups. CONCLUSION: FKB may not be mandatory and a selective FKB strategy might be more justified in one-stent techniques for bifurcation lesions.
Authors: T Lefèvre; Y Louvard; M C Morice; P Dumas; C Loubeyre; A Benslimane; R K Premchand; N Guillard; J F Piéchaud Journal: Catheter Cardiovasc Interv Date: 2000-03 Impact factor: 2.692
Authors: L Ge; I Iakovou; J Cosgrave; P Agostoni; F Airoldi; G M Sangiorgi; I Michev; A Chieffo; M Montorfano; M Carlino; N Corvaja; A Colombo Journal: Heart Date: 2005-06-17 Impact factor: 5.994
Authors: John A Ormiston; Mark W I Webster; Seifeddin El Jack; Peter N Ruygrok; James T Stewart; Douglas Scott; Erin Currie; Monique J Panther; Bronwyn Shaw; Barbara O'Shaughnessy Journal: Catheter Cardiovasc Interv Date: 2006-01 Impact factor: 2.692
Authors: Lei Ge; Flavio Airoldi; Ioannis Iakovou; John Cosgrave; Iassen Michev; Giuseppe M Sangiorgi; Matteo Montorfano; Alaide Chieffo; Mauro Carlino; Nicola Corvaja; Antonio Colombo Journal: J Am Coll Cardiol Date: 2005-08-16 Impact factor: 24.094
Authors: Javier Suárez de Lezo; Alfonso Medina; Pedro Martín; Celestina Amador; Antonio Delgado; José Suárez de Lezo; Manuel Pan; Enrique Hernández; Francisco Melián; Elena Arbelo; Antonio García Journal: Rev Esp Cardiol Date: 2008-09 Impact factor: 4.753